
Turn Therapeutics Inc.
TTRXHealthcare|Biotechnology|US
$9.48
+0.54 (+6.04%)
DCF Value
$0.18
Cash / Share
$0.35
Next Earnings Report
Nov 12, 2026
EPS est. -$0.09
Financing Filings (last 12 months)
2
Shelf registrations / offering prospectuses — latest Nov 17, 2025 (424B3). Possible dilution.
Upcoming Data Readouts (1)
Jan 2027
Est. completion
P2P3Eczema Atopic Dermatitis
A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema)
NCT07355075n=190
Recent Press Releases
Turn Therapeutics' GX-03 Earns “Developmental Immunology Solution of the Year” in 2026 BioTech Breakthrough Awards Program
Nov 5, 2026 · Business Wire
U.S. Bancorp | BTIG to Host Turn Therapeutics for Virtual Fireside Chat
Oct 21, 2026 · Business Wire
Turn Therapeutics Appoints Former CDC Director Robert R. Redfield, M.D.
Sep 9, 2026 · Business Wire
Turn Therapeutics Announces New Peer-Reviewed Research Showing GX-03 Selectively Reduces Key Drivers of Skin Inflammation and Itch
Aug 20, 2026 · Business Wire
Turn Therapeutics Provides Corporate Updates and Reports Second Quarter 2026 Financial Results
Aug 12, 2026 · Business Wire
SEC Filings (74)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Oct 19, 2026 | ARS | Annual report to holders | DocumentIndex |
| Oct 19, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Oct 7, 2026 | 8-K | Material event | DocumentIndex |
| Sep 10, 2026 | 8-K | Material event | DocumentIndex |
| Sep 9, 2026 | 8-K | Material event | DocumentIndex |
| Aug 26, 2026 | D | DocumentIndex | |
| Aug 18, 2026 | 8-K | Material event | DocumentIndex |
| Aug 17, 2026 | 8-K | Material event | DocumentIndex |
| Aug 12, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 12, 2026 | 8-K | Material event | DocumentIndex |
| Jul 28, 2026 | 8-K | Material event | DocumentIndex |
| Jul 7, 2026 | 8-K | Material event | DocumentIndex |
| Jun 3, 2026 | 8-K | Material event | DocumentIndex |
| Jun 1, 2026 | 8-K | Material event | DocumentIndex |
| May 27, 2026 | 8-K | Material event | DocumentIndex |
| May 19, 2026 | 8-K | Material event | DocumentIndex |
| May 18, 2026 | 8-K | Material event | DocumentIndex |
| May 13, 2026 | C-TR | DocumentIndex | |
| May 11, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 11, 2026 | 8-K | Material event | DocumentIndex |
| Apr 6, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Apr 2, 2026 | EFFECT | DocumentIndex | |
| Apr 2, 2026 | EFFECT | DocumentIndex | |
| Mar 31, 2026 | POS AM | DocumentIndex | |
| Mar 31, 2026 | POS AM | DocumentIndex | |
| Mar 31, 2026 | 10-K | Annual report | DocumentIndex |
| Mar 31, 2026 | 8-K | Material event | DocumentIndex |
| Mar 24, 2026 | 8-K | Material event | DocumentIndex |
| Feb 17, 2026 | 8-K | Material event | DocumentIndex |
| Feb 9, 2026 | 8-K | Material event | DocumentIndex |
| Jan 12, 2026 | 8-K | Material event | DocumentIndex |
| Jan 7, 2026 | 8-K | Material event | DocumentIndex |
| Nov 17, 2025 | 424B3 | Offering prospectus | DocumentIndex |
| Nov 17, 2025 | 424B3 | Offering prospectus | DocumentIndex |
| Nov 13, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Nov 13, 2025 | 8-K | Material event | DocumentIndex |
| Nov 12, 2025 | 8-K | Material event | DocumentIndex |
| Nov 4, 2025 | 8-K | Material event | DocumentIndex |
| Oct 30, 2025 | 8-K | Material event | DocumentIndex |
| Oct 29, 2025 | 424B5 | Offering prospectus | DocumentIndex |